drugset / Trial / NCT05271799
A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female Participants
RandomizedCrossoverOpen-labelTreatment
Summary
This study is a randomized, open-label, two periods, cross-over pharmacokinetic, safety, tolerability and relative bioavailability of gepotidacin in healthy adult male and female participants of aged 18 to 50 years.
Timeline
- Start
- 2022-03-01
- Primary completion
- 2022-04-22
- Completion
- 2022-04-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gepotidacin | Small molecule | — | Oral |
Indications
No indication recorded.